May 13, 2009 (Fort Lauderdale, Florida) — Focal/grid photocoagulation provides greater long-term improvements in visual acuity (VA) than intravitreal triamcinolone for patients with diabetic macular ...

Two large NIH-funded clinical studies have shown promising results that laser photocoagulation therapy prevents vision loss in patients with diabetic retinopathy. Results of the Diabetic Retinopathy ...

In an era when intravitreal injection has come to dominate the landscape of retinal practice, laser photocoagulation remains a feasible treatment for patients with diabetic macular edema. Based on ...

The Diabetic Retinopathy Study (DRS) investigated whether scatter (panretinal) photocoagulation, compared with indefinite deferral, could reduce the risk of vision loss from PDR. After only 2 years, ...

To evaluate the 5-year visual outcome associated with laser photocoagulation treatment of diabetic macular oedema (DMO), and to investigate the relationship between systemic factors and visual ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio While anti-VEGF therapy has proven to be ...

Diabetic eye disease is a leading cause of vision loss in individuals aged 20 to 74,(3) and diabetic macular edema (DME), left untreated, is the leading cause of blindness in diabetic patients. The ...

Consultant Vitreo-Retina Surgeon at Skipper Eye-Q Superspeciality Eye Hospitals, Dr. Zeenat Shah has called on people with diabetes to seek treatment for vision problems related to diabetes, sayings ...

Ultrawidefield and 7 field imaging determine diabetic retinopathy severity levels with good concordance. Researchers included 785 participants (mean age, 61 years; 47% women) with type 1 diabetes from ...

Digital Diagnostics and Baxter International Inc. announced a long-term strategic partnership to help front line care providers deliver high-quality care and improve care outcomes. The partnership ...